VU6010608
Code | Size | Price |
---|
TAR-T35082-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T35082-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
VU6010608 is an effective mGlu7 NAM with excellent CNS permeability and is powerful in electrophysiological studies in blocking long-term enhancement of high-frequency stimuli.
CAS:
T35082
Molecular Weight:
408.34
Purity:
0.98
SMILES:
O=C(NC1=CC(OC(F)(F)F)=CC=C1N2N=CN=C2)C3=CC=C(OC)C(OC)=C3
References
VU6010608, a Novel mGlu7 NAM from a Series of N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)benzamides Carson W. Reed, Kevin M. McGowan, Paul K. Spearing, Branden J. Stansley, Hanna F. Roenfanz, Darren W. Engers, Alice L. Rodriguez, Eileen M. Engelberg, Vincent B. Luscombe, Matthew T. Loch, Daniel H. Remke, Jerri M. Rook, Anna L. Blobaum, P. Jeffrey Conn, Colleen M. Niswender, and Craig W. Lindsley Publication Date (Web): November 8, 2017 (Letter) doi: 10.1021/acsmedchemlett.7b00429